Visual Universitätsmedizin Mainz

Dr. Joanne van Ryn

Global Director, Dabigatran Scientific Support
Department CardioMetabolic Disease Research
Boehringer Ingelheim Pharma GmbH & Co KG

Scientific profile

  • Antithrombotic and anticoagulant properties of heparin fractions and similar compounds
  • Role of thrombin inhibition in disease processes
  • Research and development of a specific reversal agent for dabigatran